Sign in

CIK 0001020214 · Accelerated filer

CERUS CORP

Sign in to watch
Ticker
CERS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
680262011
Phone
9252886000
Business address
1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
  1. ARS Other Annual Report to Security Holders
  2. DEFA14A Proxy Proxy Materials
  3. DEF 14A Proxy Proxy Statement
  4. 8-K Event Material agreement · Agreement ended · New debt or obligation
  5. 4 Open-market sale SVP Reg. & Quality sold 13,078 shares at $2.80 ($36,618)
  6. 4 Open-market sale Chief Operating Officer sold 25,356 shares at $2.80 ($70,997)
  7. 4 Open-market sale Chief Legal Officer sold 15,468 shares at $2.80 ($43,310)
  8. 4 Open-market sale President and CEO sold 60,480 shares at $2.80 ($169,344)
  9. 4 Open-market sale Chief Financial Officer sold 17,163 shares at $2.80 ($48,056)
  10. 4 Open-market sale Chief Scientific Officer sold 15,342 shares at $2.80 ($42,958)
  11. 4 Open-market sale Chief Medical Officer sold 25,353 shares at an average $2.79 ($70,781)
  12. 8-K Event Other events
  13. 4 Grant or award SVP Reg. & Quality acquired 110,000 shares (grant or award)
  14. 4 Grant or award Chief Legal Officer acquired 160,000 shares (grant or award)
  15. 4 Grant or award Chief Operating Officer acquired 240,000 shares (grant or award)
  16. 4 Grant or award President and CEO acquired 575,000 shares (grant or award)
  17. 4 Grant or award Chief Financial Officer acquired 185,000 shares (grant or award)
  18. 4 Grant or award Chief Scientific Officer acquired 110,000 shares (grant or award)
  19. 4 Grant or award Chief Medical Officer acquired 160,000 shares (grant or award)
  20. POS AM Other Post-effective Amendment for Registration Statement

Page 12 of 76 · 1,513 filings